Study finds childhood PFAS exposure, especially PFOA, linked to lower adolescent bone mineral density and possible higher ...
The U.S. FDA granted marketing authorization for ProSense in October 2025 for use in low-risk early-stage breast cancer, ...
Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that nine oral and poster ...
At the regular meeting of the Hanford Parks & Recreation Commission March 9, 2026, city staff presented a range of updates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results